- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
MEI Pharma, Inc.
San Diego, CA
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (File Nos.333-225465,333-217645,333-186070,333-184011,333-174789,333-146453, and333-136440) and Form S-8 (File Nos.333-229554,333-216103,333-213278,333-201703,333-179591,333-174790,333-169719, and333-156985) of MEI Pharma, Inc. (the “Company”) of our reports dated August 28, 2019, relating to the financial statements and the effectiveness of MEI Pharma, Inc.’s internal control over financial reporting, which appear in this Form10-K. Our report contains an explanatory paragraph regarding the Company’s change in accounting method related to revenue.
/s/ BDO USA, LLP
San Diego, California
August 28, 2019